Cite

    Silvia Park et al.. “Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.” Journal of infection, vol. 73, no. 5, 2016, pp. 496–505. http://access.bl.uk/ark:/81055/vdc_100038845844.0x000032